$ Value
$0
Shares
140,000
Price
$0
Filed
Sep 8
Insider
Name
Stewart Richard Alistair
Title
Chieve Executive Officer
CIK
0001713369
Roles
Transaction Details
Transaction Date
2025-09-04
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represent PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Commmittee of the Issuer's Board of Directors. | Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. | Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. | Represent PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Commmittee of the Issuer's Board of Directors.
Filing Info
Stewart Richard Alistair's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | ACHV | A | $0 |
| 2025-09-18 | ACHV | M | $0 |
| 2025-09-18 | ACHV | ▼ | $378K |
| 2025-09-18 | ACHV | M | $0 |
| 2025-09-18 | ACHV | M | $0 |
| 2025-09-04 | ACHV | A | $0 |
| 2025-09-04 | ACHV | A | $0 |
Other Insiders at ACHV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Oki Mark K
Chief Financial Officer
|
— | — | 2026-01-28 |
|
Stewart Richard Alistair
Chief Executive Officer
|
— | — | 2026-01-28 |
|
Goldberg Andrew D.
CEO and President
|
— | — | 2026-04-18 |
|
Wan Jerry
Principal Accounting Officer
|
— | — | 2026-01-28 |
|
Xinos Jaime
Chief Commercial Officer
|
— | — | 2026-01-28 |
|
Donnelly Craig
Chief Operations Officer
|
— | — | 2026-01-28 |
|
Rubinstein Mark Lawrence
Chief Medical Officer
|
— | — | 2026-01-28 |